Schedule 13D ownership disclosure
DECIPHERA PHARMACEUTICALS IN
Security class unavailable · CUSIP: 24344T101
Event date: 2017-10-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-305214
- Form type
- SC 13D
- Filer
- Deciphera Pharmaceuticals, Inc.
- CIK
- CIK 1654151
- Filed
- Oct 06, 2017
- Reporting period
- Oct 02, 2017
- Description
- Schedule 13D beneficial ownership